RecruitingNot ApplicableNCT06473103

Investigation of Standard Excision Surgical Margins Using Two Photon Fluorescence Microscopy


Sponsor

University of Rochester

Enrollment

52 participants

Start Date

Oct 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this clinical trial is to compare the use of two photon fluorescence microscopy for detecting residual basal cell carcinoma during standard local excision.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study is looking at the standard surgical margins (how much healthy skin is removed around a tumor) used when treating basal cell carcinoma — one of the most common types of skin cancer — without Mohs surgery. Researchers want to compare two different approaches and better understand outcomes. **You may be eligible if...** - You are currently receiving treatment for basal cell carcinoma (a type of skin cancer) at the study site - You are not having Mohs surgery (a specialized surgical technique) - You are able to read and understand the consent form **You may NOT be eligible if...** - There are no specific exclusion criteria listed for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICETwo photon fluorescence microscopy imaging

Excised tissues will be imaged with two photon fluorescence microscopy prior to submission for histological processing.


Locations(1)

Rochester Dermatologic Surgery

Victor, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06473103


Related Trials